Drug
Pyridoxine Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Appendicitis | 234 | 204.4 | 224.1 | signal |
| 2 | Ventricular Fibrillation | 190 | 137.4 | 147.9 | signal |
| 3 | Cardiogenic Shock | 225 | 126.8 | 138.5 | signal |
| 4 | Folliculitis | 104 | 80.5 | 83.7 | signal |
| 5 | Bursitis | 111 | 73.5 | 76.7 | signal |
| 6 | Incorrect Route Of Product Administration | 143 | 67.9 | 71.7 | signal |
| 7 | Helicobacter Infection | 84 | 65.8 | 67.9 | signal |
| 8 | Ascites | 242 | 65.7 | 72.2 | signal |
| 9 | Pemphigus | 101 | 64.8 | 67.4 | signal |
| 10 | Multiple Organ Dysfunction Syndrome | 217 | 62.0 | 67.5 | signal |
| 11 | Pericarditis | 126 | 60.3 | 63.3 | signal |
| 12 | Wound Infection | 80 | 58.7 | 60.5 | signal |
| 13 | Bacterial Infection | 121 | 51.9 | 54.3 | signal |
| 14 | Joint Range Of Motion Decreased | 87 | 51.9 | 53.6 | signal |
| 15 | Hand Deformity | 81 | 49.3 | 50.8 | signal |
| 16 | Obesity | 88 | 43.9 | 45.4 | signal |
| 17 | Synovitis | 99 | 43.7 | 45.3 | signal |
| 18 | Hyperlipidaemia | 65 | 43.2 | 44.2 | signal |
| 19 | Taste Disorder | 107 | 42.5 | 44.2 | signal |
| 20 | Blood Cholesterol Increased | 233 | 39.7 | 43.5 | signal |
| 21 | Neuralgia | 113 | 37.0 | 38.7 | signal |
| 22 | Irritable Bowel Syndrome | 93 | 34.6 | 35.8 | signal |
| 23 | Hyponatraemia | 238 | 33.7 | 36.9 | signal |
| 24 | Glossodynia | 87 | 30.9 | 31.9 | signal |
| 25 | Pneumonia Aspiration | 96 | 30.6 | 31.7 | signal |
| 26 | Red Blood Cell Sedimentation Rate Increased | 42 | 30.1 | 30.6 | signal |
| 27 | Back Injury | 41 | 30.1 | 30.5 | signal |
| 28 | End Stage Renal Disease | 68 | 29.3 | 30.1 | signal |
| 29 | Liver Injury | 89 | 29.2 | 30.2 | signal |
| 30 | Gout | 66 | 29.2 | 29.9 | signal |
| 31 | Epilepsy | 112 | 29.2 | 30.4 | signal |
| 32 | Fibromyalgia | 89 | 29.1 | 30.1 | signal |
| 33 | Micturition Urgency | 41 | 28.7 | 29.2 | signal |
| 34 | Ulcer | 56 | 27.9 | 28.5 | signal |
| 35 | Wound | 97 | 27.7 | 28.7 | signal |
| 36 | Blood Test Abnormal | 48 | 27.2 | 27.6 | signal |
| 37 | Head Discomfort | 59 | 26.6 | 27.2 | signal |
| 38 | Osteoarthritis | 142 | 26.5 | 28.0 | signal |
| 39 | Hypercholesterolaemia | 31 | 25.7 | 26.0 | signal |
| 40 | Lower Respiratory Tract Infection | 146 | 25.6 | 27.0 | signal |
| 41 | Nocturia | 39 | 25.6 | 25.9 | signal |
| 42 | Dry Mouth | 260 | 25.5 | 28.2 | signal |
| 43 | Toxic Epidermal Necrolysis | 48 | 25.3 | 25.7 | signal |
| 44 | General Physical Health Deterioration | 360 | 24.9 | 28.6 | signal |
| 45 | Stress | 217 | 24.0 | 26.0 | signal |
| 46 | Gastrooesophageal Reflux Disease | 239 | 23.7 | 25.9 | signal |
| 47 | Psoriatic Arthropathy | 119 | 23.5 | 24.5 | signal |
| 48 | Night Sweats | 95 | 23.4 | 24.3 | signal |
| 49 | Systemic Lupus Erythematosus | 102 | 22.9 | 23.8 | signal |
| 50 | Impaired Healing | 94 | 22.7 | 23.5 | signal |
| 51 | Abdominal Distension | 290 | 22.1 | 24.7 | signal |
| 52 | Contraindicated Product Administered | 81 | 21.3 | 22.0 | signal |
| 53 | Blood Potassium Increased | 43 | 21.0 | 21.4 | signal |
| 54 | Sleep Disorder | 180 | 20.4 | 21.8 | signal |
| 55 | Swelling | 239 | 20.3 | 22.2 | signal |
| 56 | Ataxia | 30 | 20.0 | 20.2 | signal |
| 57 | Cyst | 30 | 19.2 | 19.4 | signal |
| 58 | Chronic Obstructive Pulmonary Disease | 125 | 19.0 | 19.9 | signal |
| 59 | Type 2 Diabetes Mellitus | 79 | 18.6 | 19.1 | signal |
| 60 | Muscle Spasticity | 29 | 18.5 | 18.7 | signal |
| 61 | Aspiration | 25 | 18.3 | 18.5 | signal |
| 62 | Drug Intolerance | 222 | 18.3 | 19.9 | signal |
| 63 | Inflammation | 117 | 18.1 | 18.9 | signal |
| 64 | Liver Function Test Increased | 47 | 17.5 | 17.8 | signal |
| 65 | Stomatitis | 132 | 17.3 | 18.1 | signal |
| 66 | Sepsis | 242 | 17.2 | 18.8 | signal |
| 67 | Musculoskeletal Pain | 113 | 17.0 | 17.7 | signal |
| 68 | Lung Disorder | 103 | 16.7 | 17.3 | signal |
| 69 | Osteopenia | 32 | 16.6 | 16.8 | signal |
| 70 | C-reactive Protein Increased | 76 | 16.6 | 17.0 | signal |
| 71 | Wheezing | 123 | 16.5 | 17.2 | signal |
| 72 | Coma | 99 | 16.5 | 17.1 | signal |
| 73 | Neck Pain | 116 | 16.4 | 17.1 | signal |
| 74 | Arthropathy | 113 | 16.1 | 16.7 | signal |
| 75 | Central Nervous System Lesion | 27 | 15.5 | 15.6 | signal |
| 76 | Infusion Related Reaction | 125 | 15.0 | 15.7 | signal |
| 77 | Blister | 103 | 14.6 | 15.1 | signal |
| 78 | Deformity | 17 | 14.4 | 14.5 | signal |
| 79 | Frequent Bowel Movements | 48 | 14.1 | 14.4 | signal |
| 80 | Autoimmune Disorder | 17 | 14.1 | 14.2 | signal |
| 81 | Migraine | 166 | 13.9 | 14.7 | signal |
| 82 | Diabetes Mellitus | 131 | 13.6 | 14.2 | signal |
| 83 | Rash Papular | 38 | 13.4 | 13.6 | signal |
| 84 | Pulmonary Fibrosis | 31 | 12.9 | 13.0 | signal |
| 85 | Full Blood Count Abnormal | 17 | 12.8 | 12.9 | signal |
| 86 | Thrombosis | 130 | 12.8 | 13.4 | signal |
| 87 | Laryngitis | 17 | 12.4 | 12.5 | signal |
| 88 | Hepatic Enzyme Increased | 105 | 12.2 | 12.7 | signal |
| 89 | Blood Creatinine Increased | 100 | 12.1 | 12.6 | signal |
| 90 | Sputum Discoloured | 14 | 11.7 | 11.8 | signal |
| 91 | Maternal Exposure During Pregnancy | 127 | 11.4 | 11.9 | signal |
| 92 | Obstructive Airways Disorder | 16 | 11.4 | 11.4 | signal |
| 93 | Pulmonary Mass | 21 | 11.2 | 11.3 | signal |
| 94 | Intentional Product Misuse | 122 | 11.1 | 11.6 | signal |
| 95 | Skin Lesion | 37 | 10.8 | 10.9 | signal |
| 96 | Somnolence | 272 | 10.7 | 11.8 | signal |
| 97 | Abdominal Pain | 314 | 10.7 | 12.0 | signal |
| 98 | Vitamin D Deficiency | 13 | 10.6 | 10.6 | signal |
| 99 | Constipation | 284 | 10.4 | 11.5 | signal |
| 100 | Musculoskeletal Stiffness | 115 | 10.4 | 10.8 | signal |
| 101 | Iron Deficiency Anaemia | 12 | 10.4 | 10.4 | signal |
| 102 | Sleep Disorder Due To A General Medical Condition | 21 | 10.3 | 10.4 | signal |
| 103 | Rheumatoid Arthritis | 145 | 10.2 | 10.7 | signal |
| 104 | Blood Pressure Systolic Increased | 25 | 10.1 | 10.2 | signal |
| 105 | Pulmonary Embolism | 119 | 9.9 | 10.3 | signal |
| 106 | Rash Erythematous | 58 | 9.8 | 10.0 | signal |
| 107 | Hepatic Steatosis | 23 | 9.8 | 9.9 | signal |
| 108 | Memory Impairment | 170 | 9.8 | 10.4 | signal |
| 109 | Ear Pain | 24 | 9.8 | 9.9 | signal |
| 110 | Mobility Decreased | 87 | 9.6 | 9.9 | signal |
| 111 | Aspartate Aminotransferase Increased | 60 | 9.0 | 9.1 | signal |
| 112 | Feeling Hot | 69 | 8.9 | 9.1 | signal |
| 113 | Exposure During Pregnancy | 69 | 8.8 | 9.0 | signal |
| 114 | Drug Hypersensitivity | 215 | 8.8 | 9.5 | signal |
| 115 | Hypoaesthesia | 164 | 8.7 | 9.2 | signal |
| 116 | Dysarthria | 41 | 8.6 | 8.8 | signal |
| 117 | Erectile Dysfunction | 28 | 8.6 | 8.7 | signal |
| 118 | Therapeutic Product Effect Decreased | 48 | 8.6 | 8.7 | signal |
| 119 | Transaminases Increased | 24 | 8.6 | 8.6 | signal |
| 120 | Sciatica | 17 | 8.5 | 8.5 | signal |
| 121 | Gait Inability | 35 | 8.4 | 8.5 | signal |
| 122 | Eructation | 20 | 8.3 | 8.4 | signal |
| 123 | Paraesthesia | 164 | 8.2 | 8.7 | signal |
| 124 | Anaemia | 198 | 8.2 | 8.8 | signal |
| 125 | Prescribed Overdose | 20 | 8.2 | 8.2 | signal |
| 126 | Condition Aggravated | 310 | 8.1 | 9.1 | signal |
| 127 | Prescribed Underdose | 20 | 7.9 | 8.0 | signal |
| 128 | Joint Swelling | 120 | 7.9 | 8.2 | signal |
| 129 | Hepatotoxicity | 22 | 7.9 | 7.9 | signal |
| 130 | Abdominal Pain Upper | 202 | 7.8 | 8.4 | signal |
| 131 | Osteoporosis | 40 | 7.7 | 7.8 | signal |
| 132 | Movement Disorder | 31 | 7.6 | 7.7 | signal |
| 133 | Weight Fluctuation | 10 | 7.6 | 7.6 | signal |
| 134 | Rash Maculo-papular | 21 | 7.5 | 7.6 | signal |
| 135 | Peripheral Swelling | 144 | 7.4 | 7.8 | signal |
| 136 | Pleural Effusion | 57 | 7.4 | 7.6 | signal |
| 137 | Treatment Failure | 76 | 7.3 | 7.5 | signal |
| 138 | Hepatic Cirrhosis | 17 | 7.2 | 7.2 | signal |
| 139 | Body Temperature Decreased | 9 | 7.2 | 7.2 | signal |
| 140 | Adverse Reaction | 12 | 7.2 | 7.2 | signal |
| 141 | Joint Stiffness | 23 | 6.9 | 7.0 | signal |
| 142 | Oedema Peripheral | 107 | 6.9 | 7.2 | signal |
| 143 | Blood Pressure Fluctuation | 21 | 6.9 | 7.0 | signal |
| 144 | Vomiting | 408 | 6.9 | 8.0 | signal |
| 145 | Diverticulitis | 24 | 6.9 | 6.9 | signal |
| 146 | Oedema | 47 | 6.9 | 7.0 | signal |
| 147 | Respiratory Disorder | 26 | 6.9 | 6.9 | signal |
| 148 | Tuberculosis | 11 | 6.8 | 6.8 | signal |
| 149 | Diarrhoea Haemorrhagic | 8 | 6.8 | 6.8 | signal |
| 150 | Urticaria | 142 | 6.8 | 7.1 | signal |
| 151 | Dry Eye | 41 | 6.7 | 6.8 | signal |
| 152 | Musculoskeletal Chest Pain | 13 | 6.6 | 6.7 | signal |
| 153 | Red Blood Cell Count Decreased | 24 | 6.6 | 6.7 | signal |
| 154 | Lower Limb Fracture | 16 | 6.6 | 6.7 | signal |
| 155 | Dizziness Postural | 8 | 6.6 | 6.6 | signal |
| 156 | Haemoptysis | 23 | 6.5 | 6.6 | signal |
| 157 | Injury | 58 | 6.5 | 6.6 | signal |
| 158 | Foot Deformity | 9 | 6.4 | 6.4 | signal |
| 159 | Product Use In Unapproved Indication | 196 | 6.4 | 6.8 | signal |
| 160 | Blood Calcium Decreased | 9 | 6.3 | 6.3 | signal |
| 161 | Joint Injury | 17 | 6.3 | 6.3 | signal |
| 162 | Hypomagnesaemia | 11 | 6.3 | 6.3 | signal |
| 163 | Motor Dysfunction | 8 | 6.3 | 6.3 | signal |
| 164 | Confusional State | 128 | 6.3 | 6.5 | signal |
| 165 | Haemoglobin Decreased | 81 | 6.2 | 6.4 | signal |
| 166 | Hypertension | 165 | 6.2 | 6.5 | signal |
| 167 | Poor Venous Access | 8 | 6.1 | 6.2 | signal |
| 168 | Oral Candidiasis | 10 | 6.1 | 6.1 | signal |
| 169 | Blood Iron Decreased | 9 | 6.0 | 6.1 | signal |
| 170 | Gastrointestinal Disorder | 67 | 6.0 | 6.1 | signal |
| 171 | Neuropathy Peripheral | 71 | 5.9 | 6.1 | signal |
| 172 | Premature Delivery | 12 | 5.9 | 6.0 | signal |
| 173 | Pollakiuria | 30 | 5.7 | 5.8 | signal |
| 174 | Upper Respiratory Tract Infection | 33 | 5.7 | 5.7 | signal |
| 175 | Abdominal Discomfort | 119 | 5.6 | 5.9 | signal |
| 176 | Underdose | 52 | 5.6 | 5.7 | signal |
| 177 | Status Epilepticus | 8 | 5.6 | 5.6 | signal |
| 178 | Haematocrit Decreased | 14 | 5.6 | 5.6 | signal |
| 179 | Vaginal Discharge | 7 | 5.5 | 5.5 | signal |
| 180 | Muscle Spasms | 126 | 5.4 | 5.7 | signal |
| 181 | Sleep Apnoea Syndrome | 13 | 5.4 | 5.4 | signal |
| 182 | Discomfort | 41 | 5.4 | 5.4 | signal |
| 183 | Nasopharyngitis | 123 | 5.3 | 5.5 | signal |
| 184 | Delirium | 23 | 5.3 | 5.3 | signal |
| 185 | Joint Dislocation | 7 | 5.3 | 5.3 | signal |
| 186 | Bradycardia | 35 | 5.2 | 5.3 | signal |
| 187 | Hypophagia | 16 | 5.0 | 5.0 | signal |
| 188 | Nerve Injury | 7 | 5.0 | 5.0 | signal |
| 189 | Paraesthesia Oral | 9 | 5.0 | 5.0 | signal |
| 190 | Apathy | 9 | 4.9 | 4.9 | signal |
| 191 | Hypersensitivity | 113 | 4.8 | 5.0 | signal |
| 192 | Decreased Appetite | 137 | 4.7 | 4.9 | signal |
| 193 | Blood Bilirubin Increased | 16 | 4.7 | 4.7 | signal |
| 194 | Alopecia | 116 | 4.7 | 4.8 | signal |
| 195 | Macular Degeneration | 7 | 4.7 | 4.7 | signal |
| 196 | Rectal Haemorrhage | 25 | 4.6 | 4.6 | signal |
| 197 | Asthenia | 218 | 4.6 | 4.9 | signal |
| 198 | Renal Impairment | 48 | 4.5 | 4.6 | signal |
| 199 | Pain | 351 | 4.5 | 5.1 | signal |
| 200 | Faeces Discoloured | 12 | 4.4 | 4.4 | signal |
| 201 | Balance Disorder | 47 | 4.3 | 4.4 | signal |
| 202 | Cardiomyopathy | 8 | 4.3 | 4.3 | signal |
| 203 | Product Quality Issue | 72 | 4.2 | 4.3 | signal |
| 204 | Tooth Infection | 7 | 4.2 | 4.2 | signal |
| 205 | Nausea | 418 | 4.2 | 4.8 | signal |
| 206 | Hypocalcaemia | 10 | 4.2 | 4.2 | signal |
| 207 | Heart Rate Irregular | 12 | 4.2 | 4.2 | signal |
| 208 | Coronary Artery Disease | 16 | 4.2 | 4.2 | signal |
| 209 | Therapeutic Product Effect Incomplete | 37 | 4.1 | 4.2 | signal |
| 210 | Dyspepsia | 51 | 4.1 | 4.2 | signal |
| 211 | Sinus Bradycardia | 5 | 4.1 | 4.1 | signal |
| 212 | Off Label Use | 446 | 4.1 | 4.7 | signal |
| 213 | Lymphadenopathy | 18 | 4.0 | 4.0 | signal |
| 214 | Depression | 114 | 4.0 | 4.1 | signal |
| 215 | Weight Increased | 110 | 3.9 | 4.0 | signal |
| 216 | Inappropriate Antidiuretic Hormone Secretion | 5 | 3.9 | 3.9 | signal |
| 217 | Asthma | 55 | 3.9 | 3.9 | signal |
| 218 | Back Pain | 114 | 3.9 | 4.0 | signal |
| 219 | Thinking Abnormal | 9 | 3.8 | 3.8 | signal |
| 220 | Headache | 300 | 3.8 | 4.2 | signal |
| 221 | Immunodeficiency | 7 | 3.8 | 3.8 | signal |
| 222 | Fluid Retention | 24 | 3.7 | 3.8 | signal |
| 223 | Colitis Ulcerative | 21 | 3.7 | 3.8 | signal |
| 224 | Paranoia | 8 | 3.7 | 3.7 | signal |
| 225 | Arthralgia | 191 | 3.7 | 3.9 | signal |
| 226 | Hip Arthroplasty | 7 | 3.6 | 3.7 | signal |
| 227 | Oropharyngeal Pain | 42 | 3.6 | 3.6 | signal |
| 228 | Delusion | 7 | 3.6 | 3.6 | signal |
| 229 | Eye Haemorrhage | 6 | 3.6 | 3.6 | signal |
| 230 | Multiple Sclerosis Relapse | 31 | 3.6 | 3.6 | signal |
| 231 | Visual Impairment | 55 | 3.5 | 3.6 | signal |
| 232 | Amnesia | 29 | 3.5 | 3.5 | signal |
| 233 | Knee Arthroplasty | 9 | 3.4 | 3.4 | signal |
| 234 | Road Traffic Accident | 18 | 3.4 | 3.4 | signal |
| 235 | Vasculitis | 5 | 3.4 | 3.4 | signal |
| 236 | Rash Pruritic | 23 | 3.4 | 3.4 | signal |
| 237 | Covid-19 Pneumonia | 5 | 3.3 | 3.3 | signal |
| 238 | Polyneuropathy | 5 | 3.3 | 3.3 | signal |
| 239 | Limb Discomfort | 13 | 3.3 | 3.3 | signal |
| 240 | Muscle Rigidity | 5 | 3.3 | 3.3 | signal |
| 241 | Therapy Change | 4 | 3.3 | 3.3 | signal |
| 242 | Hyperthyroidism | 6 | 3.3 | 3.3 | signal |
| 243 | Localised Infection | 10 | 3.3 | 3.3 | signal |
| 244 | Parkinsonism | 4 | 3.2 | 3.3 | signal |
| 245 | Coeliac Disease | 4 | 3.2 | 3.2 | signal |
| 246 | Adverse Event | 37 | 3.2 | 3.2 | signal |
| 247 | Flushing | 41 | 3.2 | 3.2 | signal |
| 248 | Eosinophilia | 7 | 3.2 | 3.2 | signal |
| 249 | Sluggishness | 4 | 3.1 | 3.1 | no signal |
| 250 | Cardiovascular Disorder | 10 | 3.1 | 3.1 | signal |
| 251 | Inappropriate Schedule Of Product Administration | 68 | 3.0 | 3.1 | signal |
| 252 | Transfusion | 4 | 3.0 | 3.0 | no signal |
| 253 | Breast Cancer Metastatic | 4 | 3.0 | 3.0 | no signal |
| 254 | Akathisia | 5 | 2.9 | 2.9 | signal |
| 255 | Drug Effect Less Than Expected | 5 | 2.8 | 2.8 | signal |
| 256 | Upper Limb Fracture | 7 | 2.8 | 2.8 | signal |
| 257 | Full Blood Count Decreased | 7 | 2.7 | 2.8 | signal |
| 258 | Pregnancy | 7 | 2.7 | 2.7 | signal |
| 259 | Foetal Exposure During Pregnancy | 28 | 2.7 | 2.7 | signal |
| 260 | Procedural Pain | 9 | 2.6 | 2.6 | signal |
| 261 | Injection Site Irritation | 4 | 2.5 | 2.5 | no signal |
| 262 | Product Physical Issue | 6 | 2.4 | 2.4 | no signal |
| 263 | Cytomegalovirus Infection | 5 | 2.4 | 2.4 | no signal |
| 264 | Toxic Skin Eruption | 3 | 2.4 | 2.4 | no signal |
| 265 | Influenza Like Illness | 24 | 2.3 | 2.3 | signal |
| 266 | Rebound Effect | 3 | 2.1 | 2.1 | no signal |
| 267 | Sexual Dysfunction | 3 | 2.0 | 2.0 | no signal |
| 268 | Caesarean Section | 3 | 2.0 | 2.0 | no signal |
| 269 | Schizophrenia | 3 | 2.0 | 2.0 | no signal |
| 270 | Hepatic Cytolysis | 3 | 1.9 | 1.9 | no signal |
| 271 | Injection Site Warmth | 5 | 1.9 | 1.9 | no signal |
| 272 | Peritonitis | 5 | 1.9 | 1.9 | no signal |
| 273 | Glycosylated Haemoglobin Increased | 6 | 1.9 | 1.9 | no signal |
| 274 | Drug Reaction With Eosinophilia And Systemic Symptoms | 6 | 1.9 | 1.9 | no signal |
| 275 | Neoplasm Progression | 8 | 1.8 | 1.8 | no signal |
| 276 | Drug Toxicity | 3 | 1.7 | 1.7 | no signal |
| 277 | Palmar-plantar Erythrodysaesthesia Syndrome | 5 | 1.7 | 1.7 | no signal |
| 278 | Premature Baby | 6 | 1.6 | 1.6 | no signal |
| 279 | Injection Site Swelling | 15 | 1.6 | 1.6 | no signal |
| 280 | Injection Site Rash | 6 | 1.6 | 1.6 | no signal |
| 281 | Injection Site Mass | 7 | 1.5 | 1.5 | no signal |
| 282 | Drug Effect Decreased | 10 | 1.4 | 1.5 | no signal |
| 283 | Injection Site Erythema | 22 | 1.4 | 1.4 | no signal |
| 284 | Needle Issue | 5 | 1.4 | 1.4 | no signal |
| 285 | Drug Effective For Unapproved Indication | 5 | 1.4 | 1.4 | no signal |
| 286 | Withdrawal Syndrome | 7 | 1.3 | 1.3 | no signal |
| 287 | Injection Site Reaction | 11 | 1.3 | 1.3 | no signal |
| 288 | Product Complaint | 4 | 1.3 | 1.3 | no signal |
| 289 | Circumstance Or Information Capable Of Leading To Medication Error | 5 | 1.2 | 1.2 | no signal |
| 290 | Injection Site Pruritus | 9 | 1.1 | 1.1 | no signal |
| 291 | Injection Site Urticaria | 3 | 1.0 | 1.0 | no signal |
| 292 | Device Dislocation | 5 | 0.9 | 0.9 | no signal |